Cargando…
Validation of an Arrhythmogenic Right Ventricular Cardiomyopathy Risk-Prediction Model in a Chinese Cohort
Background: The novel arrhythmogenic right ventricular cardiomyopathy (ARVC)-associated ventricular arrhythmias (VAs) risk-prediction model endorsed by Cadrin-Tourigny et al. was recently developed to estimate visual VA risk and was identified to be more effective for predicting ventricular events t...
Autores principales: | Zhang, Nixiao, Wang, Chuangshi, Gasperetti, Alessio, Song, Yanyan, Niu, Hongxia, Gu, Min, Duru, Firat, Chen, Liang, Zhang, Shu, Hua, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999693/ https://www.ncbi.nlm.nih.gov/pubmed/35407585 http://dx.doi.org/10.3390/jcm11071973 |
Ejemplares similares
-
Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
por: Gasperetti, Alessio, et al.
Publicado: (2023) -
Changes in Exercise Capacity and Ventricular Function in Arrhythmogenic Right Ventricular Cardiomyopathy: The Impact of Sports Restriction during Follow-Up
por: Costa, Sarah, et al.
Publicado: (2022) -
Arrhythmogenic Right Ventricular Cardiomyopathy and Differential Diagnosis with Diseases Mimicking Its Phenotypes
por: Molitor, Nadine, et al.
Publicado: (2022) -
Arrhythmic risk prediction in arrhythmogenic right ventricular
cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy
risk calculator( )
por: Jordà, Paloma, et al.
Publicado: (2022) -
Novel Risk Prediction Model to Determine Adverse Heart Failure Outcomes in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2022)